- We continue to favour AEM for its AI leveraged growth profile, underpinned by sustained tailwinds and ongoing diversification.
FY25 net profit came in at S$17.1mil (+48% y-o-y) on revenue of S$399.3mil (+5% y-o-y), above expectations.
- - Read this at SGinvestors.io -
- By segment, the test cell solutions business, which made up 63% of FY25 revenue, recorded 9% y-o-y growth on the back of successful production deployment and customer acceptance of AEM’s test solutions.
- The contract manufacturing segment, contributing 35% of revenue, was flat despite softer end demand linked to global trade uncertainties. Net profit margin expanded 1.2 ppts to 4.3% given improved operating leverage as top line grew.
Resumption of dividends.
- - Read this at SGinvestors.io -
- The resumption of AEM's dividends at 1.3 Singapore cents for FY2025 (vs none in FY24) signals confidence in AEM’s turnaround.
Well positioned to benefit from multi year AI demand.
- Read more at SGinvestors.io.
